VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Gilead Sciences, Inc. vs Monolithic Power Systems, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Gilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisMonolithic Power Systems, Inc.
MPWR · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Monolithic Power Systems, Inc.'s moat claims, evidence, and risks.
View MPWR analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 67 / 100 for Monolithic Power Systems, Inc.).
- Segment focus: Gilead Sciences, Inc. has 5 segments (68.5% in HIV); Monolithic Power Systems, Inc. has 6 segments (32.5% in Enterprise Data).
- Moat breadth: Gilead Sciences, Inc. has 8 moat types across 3 domains; Monolithic Power Systems, Inc. has 4 across 3.
Primary market context
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Monolithic Power Systems, Inc.
Enterprise Data
Power management ICs and power modules for enterprise/data center servers (CPU/GPU/AI accelerators) and cloud/on-prem compute platforms
Global
OEMs/ODMs and cloud platform designers
Fabless component supplier (power semiconductors)
32.5%
Side-by-side metrics
Moat coverage
Shared moat types
Gilead Sciences, Inc. strengths
Monolithic Power Systems, Inc. strengths
Segment mix
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Monolithic Power Systems, Inc. segments
Full profile >Enterprise Data
Oligopoly
Storage and Computing
Competitive
Automotive
Oligopoly
Communications
Oligopoly
Consumer
Competitive
Industrial
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.